BioAge Labs (BIOA) Competitors $5.11 +0.21 (+4.29%) As of 09/22/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BIOA vs. NRIX, VIR, RZLT, TBPH, TYRA, ANAB, KROS, ORGO, SIGA, and SEPNShould you be buying BioAge Labs stock or one of its competitors? The main competitors of BioAge Labs include Nurix Therapeutics (NRIX), Vir Biotechnology (VIR), Rezolute (RZLT), Theravance Biopharma (TBPH), Tyra Biosciences (TYRA), AnaptysBio (ANAB), Keros Therapeutics (KROS), Organogenesis (ORGO), Siga Technologies (SIGA), and Septerna (SEPN). These companies are all part of the "pharmaceutical products" industry. BioAge Labs vs. Its Competitors Nurix Therapeutics Vir Biotechnology Rezolute Theravance Biopharma Tyra Biosciences AnaptysBio Keros Therapeutics Organogenesis Siga Technologies Septerna Nurix Therapeutics (NASDAQ:NRIX) and BioAge Labs (NASDAQ:BIOA) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability. Does the media favor NRIX or BIOA? In the previous week, Nurix Therapeutics had 6 more articles in the media than BioAge Labs. MarketBeat recorded 6 mentions for Nurix Therapeutics and 0 mentions for BioAge Labs. Nurix Therapeutics' average media sentiment score of 0.64 beat BioAge Labs' score of 0.00 indicating that Nurix Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Nurix Therapeutics Positive BioAge Labs Neutral Which has better valuation and earnings, NRIX or BIOA? BioAge Labs has lower revenue, but higher earnings than Nurix Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNurix Therapeutics$54.55M11.81-$193.57M-$2.61-3.23BioAge LabsN/AN/A-$71.11MN/AN/A Do analysts rate NRIX or BIOA? Nurix Therapeutics presently has a consensus target price of $29.07, suggesting a potential upside of 244.86%. Given Nurix Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Nurix Therapeutics is more favorable than BioAge Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nurix Therapeutics 0 Sell rating(s) 3 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.88BioAge Labs 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is NRIX or BIOA more profitable? BioAge Labs has a net margin of 0.00% compared to Nurix Therapeutics' net margin of -234.57%. BioAge Labs' return on equity of -25.39% beat Nurix Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Nurix Therapeutics-234.57% -45.26% -34.71% BioAge Labs N/A -25.39%-23.22% SummaryNurix Therapeutics beats BioAge Labs on 7 of the 11 factors compared between the two stocks. Get BioAge Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIOA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOA vs. The Competition Export to ExcelMetricBioAge LabsPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$175.66M$865.14M$2.53B$10.46BDividend YieldN/A4.84%2.50%4.57%P/E RatioN/A1.1726.3326.86Price / SalesN/A25.98117.29125.65Price / CashN/A17.6550.6131.15Price / Book0.576.4934.596.50Net Income-$71.11M-$3.95M$14.12M$271.25M7 Day Performance4.29%-0.22%0.96%3.22%1 Month Performance10.85%6.00%3.95%8.11%1 Year PerformanceN/A22.53%17.65%26.42% BioAge Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOABioAge LabsN/A$5.11+4.3%N/AN/A$175.66MN/A0.00N/ANRIXNurix Therapeutics1.9806 of 5 stars$9.04-1.7%$29.07+221.6%-67.1%$703.33M$88.38M-3.46300VIRVir Biotechnology3.4985 of 5 stars$5.00-4.4%$26.80+436.0%-32.1%$694.58M$14.39M-1.25580RZLTRezolute3.3353 of 5 stars$7.69-3.5%$11.67+51.7%+60.2%$693.36MN/A-6.6940Positive NewsEarnings ReportAnalyst ForecastAnalyst RevisionTBPHTheravance Biopharma3.2872 of 5 stars$14.30+4.4%$23.00+60.8%+75.7%$689.95M$64.38M59.58110TYRATyra Biosciences1.774 of 5 stars$12.52+0.4%$31.86+154.5%-47.1%$664.61MN/A-7.0320ANABAnaptysBio2.1516 of 5 stars$23.40+0.9%$46.13+97.1%-44.4%$649.53M$91.28M-5.22100KROSKeros Therapeutics3.3343 of 5 stars$15.66-0.6%$30.00+91.6%-71.5%$640.09M$232.84M50.52100Positive NewsORGOOrganogenesis3.8383 of 5 stars$4.93-2.2%$7.50+52.1%+66.8%$639.36M$429.31M-35.21950Positive NewsSIGASiga Technologies2.0187 of 5 stars$8.92-1.7%N/A+11.2%$638.73M$179.64M7.8940SEPNSepterna1.431 of 5 stars$14.28-1.0%$26.75+87.3%N/A$636.67M$726K-1.42N/AAnalyst Upgrade Related Companies and Tools Related Companies NRIX Alternatives VIR Alternatives RZLT Alternatives TBPH Alternatives TYRA Alternatives ANAB Alternatives KROS Alternatives ORGO Alternatives SIGA Alternatives SEPN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIOA) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioAge Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioAge Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIOA Stock Alerts